Latest AVITA MEDICAL (ASX:AVH) News

Page 3

Page 3 of 3

AVITA Medical Unveils Cohealyx, Boosting Burn Care Market Potential to $1.5B

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

Ada Torres

14 Feb 2025

AVITA Medical Accelerates Growth with New FDA Approvals and 30% Revenue Surge

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Ada Torres

14 Feb 2025